Literature DB >> 27324990

Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat Pancreas.

Andrew J Long1, Erik Sampson2, Richard W McCarthy2, Christopher M Harris2, Marc Barnard2, Dan Shi2, Donna Conlon2, Robert Caldwell3, David Honor2, Neil Wishart2, Michael Hoemann2, Lori Duggan2, Douglas Fritz2, Christopher Stedman2, Elizabeth O'Connor2, Igor Mikaelian2, Annette Schwartz2.   

Abstract

Spleen tyrosine kinase (Syk) is a nonreceptor tyrosine kinase that is an important signaling enzyme downstream of immunoreceptors containing an intracellular immunoreceptor tyrosine activating motif (ITAM). These receptors encompass a wide variety of biological functions involved in autoimmune disease pathogenesis. There has been considerable interest in the development of inhibitors of the Syk pathway for the treatment of rheumatoid arthritis and systemic lupus erythematosus. We report that Syk inhibition mechanistically caused peri-islet hemorrhages and fibrin deposition in the rat pancreas and that this finding is due to a homeostatic functional defect in platelets. In more limited studies, similar lesions could not be induced in mice, dogs, and cynomolgus monkeys at similar or higher plasma drug concentrations. Irradiation-induced thrombocytopenia caused a phenotypically similar peri-islet pancreas lesion and the formation of this lesion could be prevented by platelet transfusion. In addition, Syk inhibitor-induced lesions were prevented by the coadministration of prednisone. A relatively greater sensitivity of rat platelets to Syk inhibition was supported by functional analyses demonstrating rat-specific differences in response to convulxin, a glycoprotein VI agonist that signals through Syk. These data demonstrate that the Syk pathway is critical in platelet-endothelial cell homeostasis in the peri-islet pancreatic microvasculature in rats.
© The Author(s) 2016.

Entities:  

Keywords:  Syk; hemorrhage; islet; pancreas; platelet; rat; toxicity

Mesh:

Substances:

Year:  2016        PMID: 27324990     DOI: 10.1177/0192623316654015

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  3 in total

1.  GSK2646264, a spleen tyrosine kinase inhibitor, attenuates the release of histamine in ex vivo human skin.

Authors:  Cesar Ramirez Molina; Sidsel Falkencrone; Per S Skov; Edward Hooper-Greenhill; Mike Barker; Marion C Dickson
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

2.  Spleen tyrosine kinase promotes NLR family pyrin domain containing 3 inflammasome‑mediated IL‑1β secretion via c‑Jun N‑terminal kinase activation and cell apoptosis during diabetic nephropathy.

Authors:  Yingchun Qiao; Xixi Tian; Li Men; Shengyu Li; Yufeng Chen; Meiting Xue; Yahui Hu; Pengfei Zhou; Guangfeng Long; Yue Shi; Ruiqing Liu; Yunde Liu; Zhi Qi; Yujie Cui; Yanna Shen
Journal:  Mol Med Rep       Date:  2018-06-14       Impact factor: 2.952

Review 3.  On the dynamics of the human endocrine pancreas and potential consequences for the development of type 1 diabetes.

Authors:  Oskar Skog; Olle Korsgren
Journal:  Acta Diabetol       Date:  2019-09-13       Impact factor: 4.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.